Literature DB >> 16828753

Impacts of two point mutations of RPE65 from Leber's congenital amaurosis on the stability, subcellular localization and isomerohydrolase activity of RPE65.

Ying Chen1, Gennadiy Moiseyev, Yusuke Takahashi, Jian-Xing Ma.   

Abstract

RPE65, a membrane-associated protein in the retinal pigment epithelium, is the isomerohydrolase essential for regenerating 11-cis retinal, the chromophore for visual pigments. RPE65 mutations are associated with inherited retinal dystrophies. Here we report that single point mutations of RPE65, Y144D and P363T, identified in patients with Leber's congenital amaurosis (LCA), significantly decreased the stability of RPE65. Moreover, these mutations altered subcellular localization of RPE65 and abolished its isomerohydrolase activity. These observations suggest that the decreased protein stability and altered subcellular localization of RPE65 may represent a mechanism for these mutations to lead to vision loss in LCA patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828753     DOI: 10.1016/j.febslet.2006.06.078

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

Review 1.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

2.  Functional Rescue of Retinal Degeneration-Associated Mutant RPE65 Proteins.

Authors:  Minghao Jin; Songhua Li; Jane Hu; Heather H Jin; Samuel G Jacobson; Dean Bok
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 3.  RPE65: role in the visual cycle, human retinal disease, and gene therapy.

Authors:  Xue Cai; Shannon M Conley; Muna I Naash
Journal:  Ophthalmic Genet       Date:  2009-06       Impact factor: 1.803

4.  FATP1 inhibits 11-cis retinol formation via interaction with the visual cycle retinoid isomerase RPE65 and lecithin:retinol acyltransferase.

Authors:  Thomas J P Guignard; Minghao Jin; Marie O Pequignot; Songhua Li; Yolaine Chassigneux; Karim Chekroud; Laurent Guillou; Eric Richard; Christian P Hamel; Philippe Brabet
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

5.  Identification of a novel palmitylation site essential for membrane association and isomerohydrolase activity of RPE65.

Authors:  Yusuke Takahashi; Gennadiy Moiseyev; Zsolt Ablonczy; Ying Chen; Rosalie K Crouch; Jian-Xing Ma
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

6.  Temperature-sensitive retinoid isomerase activity of RPE65 mutants associated with Leber Congenital Amaurosis.

Authors:  Songhua Li; Jane Hu; Robin J Jin; Ashok Aiyar; Samuel G Jacobson; Dean Bok; Minghao Jin
Journal:  J Biochem       Date:  2015-03-09       Impact factor: 3.387

7.  Complementation test of Rpe65 knockout and tvrm148.

Authors:  Charles B Wright; Micah A Chrenek; Stephanie L Foster; Todd Duncan; T Michael Redmond; Machelle T Pardue; Jeffrey H Boatright; John M Nickerson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-30       Impact factor: 4.799

8.  Photoreceptor layer topography in children with leber congenital amaurosis caused by RPE65 mutations.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Tomas S Aleman; Alexander Sumaroka; Elizabeth A M Windsor; Sharon B Schwartz; Elise Heon; Edwin M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-06       Impact factor: 4.799

9.  Fatty acid transport protein 4 (FATP4) prevents light-induced degeneration of cone and rod photoreceptors by inhibiting RPE65 isomerase.

Authors:  Songhua Li; Jungsoo Lee; Yongdong Zhou; William C Gordon; James M Hill; Nicolas G Bazan; Jeffrey H Miner; Minghao Jin
Journal:  J Neurosci       Date:  2013-02-13       Impact factor: 6.167

10.  Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations.

Authors:  Samuel G Jacobson; Tomas S Aleman; Artur V Cideciyan; Alejandro J Roman; Alexander Sumaroka; Elizabeth A M Windsor; Sharon B Schwartz; Elise Heon; Edwin M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-30       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.